EP Patent

EP3593819A1 — Compositions for therapeutic uses containing 5-htp and carbidopa

Assigned to Medday Pharmaceuticals · Expires 2020-01-15 · 6y expired

What this patent protects

The invention relates to a powder composition containing 5-HTP and carbidopa and its use for obtaining a suspension solution for use for treating various diseases and disorders.

USPTO Abstract

The invention relates to a powder composition containing 5-HTP and carbidopa and its use for obtaining a suspension solution for use for treating various diseases and disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP3593819A1
Jurisdiction
EP
Classification
—
Expires
2020-01-15
Drug substance claim
No
Drug product claim
No
Assignee
Medday Pharmaceuticals
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.